Doravirine / 1338225-97-0

• Post Date:

  Aug 18,2016

• Expiry Date:

  Aug 18,2017

• Detailed Description:

  Cas No. :1338225-97-0 Quantity: 0.1Kilograms
  Specs:98%min
  Payment Method: T/T
  Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor under development for use in the treatment of HIV/AIDS. Doravirine demonstrated robust antiviral activity and good tolerability in a small clinical study of 7-day monotherapy reported at the 20th Conference on Retroviruses and Opportunistic Infections in March 2013. Doravirine appeared safe and generally well tolerated with most adverse events being mild-to-moderate.

• CAS Registry Number:

  1338225-97-0

• Company:

  Shanghai Biopharmaleader Co.,Ltd     [ China ]        

• Contact:

  Brenda Xu

• Tel:

  021-50180596

• Fax:

  021-57758967

• Email:

  brenda@biopharmaleader.com